Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screening

(MedPage Today) -- Hepatocellular carcinoma (HCC) risk declined but remained high enough for screening in the first 7 years for some patients cured of their hepatitis C virus infections with direct-acting antivirals, an observational study showed...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news